NO994673D0 - Nye terapeutiske kombinasjoner av mirtazapin og antipsykotiske midler for behandling eller profylakse av psykotiske lidelser - Google Patents

Nye terapeutiske kombinasjoner av mirtazapin og antipsykotiske midler for behandling eller profylakse av psykotiske lidelser

Info

Publication number
NO994673D0
NO994673D0 NO994673A NO994673A NO994673D0 NO 994673 D0 NO994673 D0 NO 994673D0 NO 994673 A NO994673 A NO 994673A NO 994673 A NO994673 A NO 994673A NO 994673 D0 NO994673 D0 NO 994673D0
Authority
NO
Norway
Prior art keywords
mirtazapine
antipsychotics
prophylaxis
treatment
new therapeutic
Prior art date
Application number
NO994673A
Other languages
English (en)
Other versions
NO994673L (no
Inventor
Christophorus Louis Broekkamp
Hermanus Henricus Ge Berendsen
Roger Martin Pinder
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO994673D0 publication Critical patent/NO994673D0/no
Publication of NO994673L publication Critical patent/NO994673L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19994673A 1997-03-27 1999-09-24 Nye terapeutiske kombinasjoner av mirtazapin og antipsykotiske midler og anvendelse derav NO994673L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97200881 1997-03-27
EP97202785 1997-09-11
PCT/EP1998/001920 WO1998043646A1 (en) 1997-03-27 1998-03-25 New therapeutic combinations of mirtazapine and antipsychotic agents, for the treatment or prophylaxis of psychotic disorders

Publications (2)

Publication Number Publication Date
NO994673D0 true NO994673D0 (no) 1999-09-24
NO994673L NO994673L (no) 1999-11-17

Family

ID=26146283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994673A NO994673L (no) 1997-03-27 1999-09-24 Nye terapeutiske kombinasjoner av mirtazapin og antipsykotiske midler og anvendelse derav

Country Status (25)

Country Link
EP (1) EP0969845B1 (no)
JP (2) JP4377456B2 (no)
KR (1) KR100577865B1 (no)
CN (1) CN1226036C (no)
AR (1) AR012193A1 (no)
AT (1) ATE318604T1 (no)
AU (1) AU726194B2 (no)
BR (1) BR9808077A (no)
CA (1) CA2284551C (no)
CZ (1) CZ298105B6 (no)
DE (1) DE69833645T2 (no)
DK (1) DK0969845T3 (no)
ES (1) ES2259207T3 (no)
HK (1) HK1023293A1 (no)
HU (1) HUP0002742A3 (no)
ID (1) ID22283A (no)
IL (1) IL123716A (no)
NO (1) NO994673L (no)
NZ (1) NZ337618A (no)
PL (1) PL191449B1 (no)
PT (1) PT969845E (no)
RU (1) RU2222330C2 (no)
TR (1) TR199902334T2 (no)
TW (1) TW587938B (no)
WO (1) WO1998043646A1 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6280763B1 (en) 1999-05-10 2001-08-28 Pierce Management, Llc Apparatus and method for transdermal delivery of bupropion
FR2797399B1 (fr) * 1999-08-13 2002-10-18 Aventis Pharma Sa Utilisation de la cyamemazine dans le traitement du sevrage aux benzodiazepines
FR2802101B1 (fr) 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
US6350773B1 (en) 1999-12-10 2002-02-26 American Home Products Corporation Therapeutic combinations of (S)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro 7H-1,4-dioxino{2,3-e}indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders
RU2268725C2 (ru) * 2000-01-19 2006-01-27 Акцо Нобель Н.В. Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
US6495154B1 (en) * 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
EP1795199A3 (en) * 2001-02-06 2007-07-25 AstraZeneca AB Quetiapine for the treatment of substance dependence or substance abuse
ATE360425T1 (de) 2001-02-06 2007-05-15 Astrazeneca Ab Verwendung von quetiapin für die behandlung von kokain-abhängigkeit
JP5547865B2 (ja) 2003-10-29 2014-07-16 ワイス・エルエルシー アプリンドルおよびその誘導体を含む持続放出型医薬組成物
PT1541197E (pt) * 2003-12-02 2009-06-04 Pharmaneuroboost N V Utilização de pipamperona e de um sndri, snri ou ssri para o tratamento de patologias do temperamento ou da ansiedade
US7884096B2 (en) 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1547650A1 (en) * 2003-12-02 2005-06-29 B & B Beheer NV Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7855195B2 (en) 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
WO2005053796A1 (en) * 2003-12-02 2005-06-16 B & B Beheer Nv Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
WO2005117916A1 (en) 2004-06-03 2005-12-15 F. Hoffmann-La Roche Ag Treatment with cisplatin and an egfr-inhibitor
AU2007255724B2 (en) * 2006-06-09 2012-05-10 Dainippon Sumitomo Pharma Co., Ltd. Novel tape preparation
JOP20120083B1 (ar) * 2011-04-05 2021-08-17 Otsuka Pharma Co Ltd توليفات تشتمل على بريكس ببرازول أو ملح منه وعقار ثاني للاستخدام في علاج اضطراب cns
DE102012011839B4 (de) 2012-06-14 2018-03-22 Norbert Müller Verwendung von Interferon-gamma in einem Verfahren zur Behandlung von psychiatrischen Erkrankungen
RU2509560C1 (ru) * 2013-03-22 2014-03-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" Новые терапевтические комбинации миртазапина для применения при болевых расстройствах

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2410821A1 (de) * 1974-03-07 1975-09-18 Hoechst Ag Pharmazeutische kombinationspraeparate mit psychotroper wirkung und verfahren zu ihrer herstellung
CA1327008C (en) * 1988-01-15 1994-02-15 Walter Merz Anti-psychotic imidazobenzodiazepine
EP0431663B1 (en) * 1989-12-06 1994-01-12 Akzo Nobel N.V. Stabilized solutions of psychotropic agents
ZA935078B (en) * 1992-07-15 1994-02-07 Nicolaas Johannes Jaco Loetter Pharmaceutical composition
EP0669128B1 (en) * 1992-11-17 2000-01-05 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release microsphere containing antipsychotic and process for producing the same
JPH07242669A (ja) * 1994-03-07 1995-09-19 Akikazu Ogawa 四環系とブチロフェノン誘導体を化学結合した化合物

Also Published As

Publication number Publication date
NZ337618A (en) 2000-06-23
HUP0002742A3 (en) 2003-03-28
PL191449B1 (pl) 2006-05-31
ATE318604T1 (de) 2006-03-15
DE69833645D1 (de) 2006-04-27
EP0969845A1 (en) 2000-01-12
BR9808077A (pt) 2000-03-08
EP0969845B1 (en) 2006-03-01
TR199902334T2 (xx) 2000-01-21
CA2284551C (en) 2007-06-12
PL335890A1 (en) 2000-05-22
NO994673L (no) 1999-11-17
HK1023293A1 (en) 2000-09-08
JP2001521497A (ja) 2001-11-06
TW587938B (en) 2004-05-21
RU2222330C2 (ru) 2004-01-27
ID22283A (id) 1999-09-30
WO1998043646A1 (en) 1998-10-08
DK0969845T3 (da) 2006-06-19
AU7213998A (en) 1998-10-22
KR20010005677A (ko) 2001-01-15
CZ298105B6 (cs) 2007-06-27
JP5023315B2 (ja) 2012-09-12
AU726194B2 (en) 2000-11-02
HUP0002742A2 (hu) 2001-05-28
CN1251526A (zh) 2000-04-26
JP4377456B2 (ja) 2009-12-02
DE69833645T2 (de) 2006-08-24
CN1226036C (zh) 2005-11-09
KR100577865B1 (ko) 2006-05-10
CZ343199A3 (cs) 2000-04-12
IL123716A (en) 2001-03-19
ES2259207T3 (es) 2006-09-16
AR012193A1 (es) 2000-09-27
CA2284551A1 (en) 1998-10-08
JP2009280596A (ja) 2009-12-03
IL123716A0 (en) 1998-12-06
PT969845E (pt) 2006-05-31

Similar Documents

Publication Publication Date Title
NO994673D0 (no) Nye terapeutiske kombinasjoner av mirtazapin og antipsykotiske midler for behandling eller profylakse av psykotiske lidelser
NO972972D0 (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
DE60026996D1 (de) Plasmabehandlungsapparat, dessen elektrodenstruktur und struktur der bühne
NO20001754D0 (no) Prostaglandinagonister og anvendelse derav for behandling av benforstyrrelser
NO994014D0 (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
NO996483D0 (no) Imidazopyrimidiner og imidazopyridiner for behandling av neurologiske forstyrrelser
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
DE69620306T2 (de) 4-(.Alpha.-hydroxy-.alpha.-aryl-alkylcarbonylamino)-Piperidine zur Behandlung und Prophylaxe von Erkrankungen der Harnwege
EE200200442A (et) Piperasiini ja piperidiini derivaadid neuronaalsete kahjustuste raviks
NO990433D0 (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
NO20043085L (no) Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
SI1231920T1 (sl) Uporaba epinastina za zdravljenje alergijskega renitisa/konjuktivitisa
NO20031903L (no) Nye amidoalkylpiperidin- og amidoalkylpiperazinderivater for anvendelse vedbehandling av nervesystemlidelser
NO20014617D0 (no) 1-Arensulfonyl-2-aryl-pyrrolidin- og -piperidin-derivater for behandling av CNS-sykdommer
NO20005885D0 (no) Kombinasjonsterapi for behandling av refraktær depresjon
NO20023448L (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
NO20010456L (no) Triazolopyridiner for behandling av trombose lidelser
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20001758D0 (no) Fremgangsmåter og blandinger for behandling av leddgikt
NO20011892L (no) 3-tetrahydropyridin-4-yl-indoler for behandling av psykotiske forstyrrelser
NO984624L (no) Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
DE59711240D1 (de) Verwendung von flupirtin zur therapie und prophylaxe von myokardinfarkt, schockniere und schocklunge
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application